NFA
NKTR icon

Nationwide Fund Advisors’s Nektar Therapeutics NKTR Stock Holding History

Nationwide Fund Advisors’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,992
Closed -$4.32M – 1368
2017
Q3 		$4.32M Buy
11,992
+4,822
+67% +$1.51M 0.02% 1089
2017
Q2 		$2.1M Buy
7,170
+1,658
+30% +$479K 0.01% 1409
2017
Q1 		$1.94M Sell
5,512
-394
-7% -$88.6K 0.01% 1411
2016
Q4 		$1.09M Buy
5,906
+316
+6% +$64.2K ﹤0.01% 1725
2016
Q3 		$1.44M Sell
5,590
-51
-0.9% -$13.1K 0.01% 1568
2016
Q2 		$1.2M Sell
5,641
-37
-0.7% -$8.27K 0.01% 1615
2016
Q1 		$1.19M Sell
5,678
-93
-2% -$17.9K 0.01% 1614
2015
Q4 		$1.46M Buy
5,771
+119
+2% +$24.5K 0.01% 1517
2015
Q3 		$929K Sell
5,652
-45
-0.8% -$7.96K ﹤0.01% 1765
2015
Q2 		$1.07M Sell
5,697
-1,968
-26% -$339K ﹤0.01% 1813
2015
Q1 		$1.26M Sell
7,665
-201
-3% -$41.3K 0.01% 1765
2014
Q4 		$1.83M Buy
7,866
+78
+1% +$16.7K 0.01% 1469
2014
Q3 		$1.41M Buy
7,788
+7
+0.1% +$1.34K 0.01% 1640
2014
Q2 		$1.5M Buy
7,781
+102
+1% +$18K 0.01% 1651
2014
Q1 		$1.4M Buy
7,679
+481
+7% +$95.2K 0.01% 1571
2013
Q4 		$1.23M Sell
7,198
-89
-1% -$14.4K 0.01% 1758
2013
Q3 		$1.14M Buy
7,287
+1,457
+25% +$269K 0.01% 1777
2013
Q2 		$1.01M Buy
+5,830
New +$894K 0.01% 1673

Other funds holding NKTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Nationwide Fund Advisors's NKTR Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Nektar Therapeutics (NKTR) in Q4 2017, closing a stake of 11,992 shares — an estimated $4.32M sold.

Nationwide Fund Advisors first reported a position in NKTR in Q2 2013 and held it in 18 quarters. The position peaked at $4.32M in Q3 2017. 265 funds tracked by Wall St. Rank hold NKTR as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Nektar Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 11,992 Nektar Therapeutics shares in Q4 2017, an estimated $4.32M.
  • Nationwide Fund Advisors first reported a position in Nektar Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Nektar Therapeutics position peaked at $4.32M in Q3 2017.
  • 265 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.